Articles

Working the crowd

Open-access communities launch to support drug discovery efforts
Written byKelsey Kaustinen
| 3 min read

KIEV, Ukraine & SANKT AUGUSTIN, Germany—Crowdsourcing is far from a new tactic, being as it is a cheaper and sometimes faster option of advancing new ideas, especially for individuals or smaller organizations. But now this approach is being harnessed by a handful of larger pharmaceutical firms as well, in separate efforts aimed at spurring the identification of promising new molecules and finding therapeutics for a neglected disease.

Chemical research organization Enamine Ltd., which boasts the world's largest collections of building blocks and screening compound libraries, and BioSolveIT GmbH have launched the REAL Space Navigator, a jointly developed software tool that leverages Enamine's REAL (readily accessible) virtual compound concept. This new tool offers easy search-and-find access to more than 640 million pharmaceutical-oriented molecules, making it the largest chemical space of commercially accessible compounds to date.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.